Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. (FRTX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 53 transactions totaling $1.0M, demonstrating a bullish sentiment with $1.0M in net insider flow. The most recent transaction on Jun 10, 2024 involved a purchase of 86,185 shares valued at $81.0K.
FRTX Insider Activity Summary
Who Is Buying FRTX Stock?
No significant insider buying has been recorded for FRTX in the recent period.
Who Is Selling FRTX Stock?
No significant insider selling has been recorded for FRTX in the recent period.
Is Fresh Tracks Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FRTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
FRTX Frequently Asked Questions
Understanding FRTX Insider Activity
Insider trading at Fresh Tracks Therapeutics, Inc. (FRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading FRTX stock, having executed 53 transactions in the past 90 days. The most active insider is Capital, Llc Exploration (Executive), who has made 42 transactions totaling $1.0M.
Related Tools
Track Fresh Tracks Therapeutics, Inc. Insider Activity
Get notified when executives and directors at FRTX file new Form 4 transactions